Clinical Trial Update: Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating RVT-501 topical ointment in pediatric patients with atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• RVT-501 topical ointment (RVT-501)

Snippet

Sponsor: Dermavant Sciences GmbH | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED